logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-07-15 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $24.80 - $24.80 $31,496
2024-07-12 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 50000 $25.01 - $25.07 $1,252,825
2024-07-12 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 3000 $25.07 - $25.07 $75,195
2024-07-12 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 3000 $2.48 - $2.48 $7,440
2024-06-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 4250 $21.79 - $23.43 $95,921
2024-06-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 4250 $2.48 - $2.48 $10,540
2024-06-25 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
S Common Stock D 12000 $21.63 - $22.30 $259,901
2024-06-17 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $21.48 - $21.48 $27,277
2024-06-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 1133 $20.06 - $20.06 $22,722
2024-06-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
M Common Stock A 1133 $2.48 - $2.48 $2,809
2024-05-28 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
S Common Stock D 12000 $22.86 - $24.34 $278,209
2024-05-28 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-05-28 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 4250 $22.89 - $24.34 $98,529
2024-05-28 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 4250 $2.48 - $2.48 $10,540
2024-05-16 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $23.74 - $23.74 $30,149
2024-05-16 Enliven Therapeutics, Inc. Gupta Rishi
(Director)
S Common Stock D 1033300 $22.14 - $22.14 $22,877,262
2024-05-14 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 1107 $25.00 - $25.00 $27,675
2024-05-14 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
M Common Stock A 1107 $2.48 - $2.48 $2,745
2024-05-09 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 260 $25.06 - $25.06 $6,515
2024-05-09 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
M Common Stock A 260 $2.48 - $2.48 $644
2024-05-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 4875 $22.72 - $22.72 $110,769
2024-05-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
M Common Stock A 4875 $2.48 - $2.48 $12,090
2024-05-03 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 1000 $22.50 - $22.50 $22,500
2024-05-03 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 1000 $2.48 - $2.48 $2,480
2024-04-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
S Common Stock D 12000 $17.86 - $18.48 $214,987
2024-04-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-04-29 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 3250 $16.97 - $16.97 $55,164
2024-04-29 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 3250 $2.48 - $2.48 $8,060
2024-04-25 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
S Common Stock D 12000 $16.89 - $16.89 $202,700
2024-04-25 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-04-11 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 17500 $25.03 - $25.03 $438,098
2024-04-11 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
M Common Stock A 14903 $2.48 - $2.48 $36,959
2024-04-11 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
S Common Stock D 30000 $25.04 - $25.04 $751,332
2024-04-11 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
M Common Stock A 30000 $1.12 - $1.12 $33,600
2024-04-11 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
S Common Stock D 47709 $25.04 - $25.04 $1,194,700
2024-04-11 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
M Common Stock A 47709 $1.12 - $1.12 $53,434
2024-04-11 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 14000 $23.88 - $25.04 $346,148
2024-04-11 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 14000 $2.48 - $2.48 $34,720
2024-04-11 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 6964 $19.94 - $25.03 $167,886
2024-04-11 Enliven Therapeutics, Inc. Collins Helen Louise
(CHIEF MEDICAL OFFICER)
S Common Stock D 20000 $25.07 - $25.07 $501,477
2024-04-11 Enliven Therapeutics, Inc. Collins Helen Louise
(CHIEF MEDICAL OFFICER)
M Common Stock A 20000 $2.48 - $2.48 $49,600
2024-04-10 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
S Common Stock D 67000 $21.01 - $25.21 $1,564,810
2024-04-10 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
M Common Stock A 67000 $12.60 - $19.68 $876,626
2024-04-08 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 4875 $18.50 - $19.40 $90,686
2024-04-04 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
S Common Stock D 3485 $19.15 - $19.15 $66,729
2024-04-04 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
M Common Stock A 3485 $12.60 - $12.60 $43,911
2024-04-01 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
S Common Stock D 3237 $19.08 - $19.08 $61,758
2024-04-01 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
M Common Stock A 3237 $5.52 - $12.60 $18,533
2024-04-01 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
S Common Stock D 12000 $17.72 - $19.36 $223,144
2024-04-01 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-03-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 3250 $18.22 - $18.72 $59,301
2024-03-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 3250 $2.48 - $2.48 $8,060
2024-03-25 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
S Common Stock D 12000 $17.17 - $18.16 $210,660
2024-03-25 Enliven Therapeutics, Inc. Kintz Samuel
(PRESIDENT AND CEO)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-03-20 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
S Common Stock D 13278 $19.16 - $19.16 $254,462
2024-03-20 Enliven Therapeutics, Inc. Ballal Rahul D.
(Director)
M Common Stock A 13278 $5.52 - $5.52 $73,294
2024-03-19 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $14.50 - $14.50 $18,418
2024-03-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 4875 $15.64 - $15.64 $76,238
2024-02-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
S Common Stock D 12000 $16.30 - $17.09 $197,005
2024-02-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-02-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 3250 $16.97 - $16.97 $55,162
2024-02-27 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 3250 $2.48 - $2.48 $8,060
2024-02-15 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $17.42 - $17.42 $22,117
2024-02-06 Enliven Therapeutics, Inc. Patel Anish
(CHIEF OPERATING OFFICER)
S Common Stock D 4875 $15.11 - $15.11 $73,658
2024-01-30 Enliven Therapeutics, Inc. Heyman Richard A.
(Director)
S Common Stock D 1270 $16.41 - $16.41 $20,839
2024-01-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
S Common Stock D 12000 $15.85 - $15.85 $190,256
2024-01-29 Enliven Therapeutics, Inc. Lyssikatos Joseph P
(CHIEF SCIENTIFIC OFFICER)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-01-29 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
S Common Stock D 3250 $15.81 - $15.81 $51,388
2024-01-29 Enliven Therapeutics, Inc. Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
M Common Stock A 3250 $2.48 - $2.48 $8,060
2024-01-25 Enliven Therapeutics, Inc. Kintz Samuel
(President and CEO)
S Common Stock D 12000 $14.94 - $15.89 $188,229
2024-01-25 Enliven Therapeutics, Inc. Kintz Samuel
(President and CEO)
M Common Stock A 12000 $1.12 - $1.12 $13,440
2024-01-22 Enliven Therapeutics, Inc. Patel Anish
(Chief Operating Officer)
S Common Stock D 4875 $15.13 - $15.13 $73,783
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6